Left bundle branch area pacing in mildly reduced heart failure: A systematic literature review and meta‐analysis

Cardiac resynchronization therapy (CRT) strategy for heart failure with mildly reduced ejection fraction (HFmrEF) is controversial. Left bundle branch area pacing (LBBAP) is an emerging pacing modality and an alternative option to CRT. This analysis aimed to perform a systematic review of the literature and meta‐analysis on the impact of the LBBAP strategy in HFmrEF, with left ventricular ejection fraction (LVEF) between 35% and 50%. PubMed, Embase, and Cochrane Library were searched for full‐text articles on LBBAP from inception to July 17, 2022. The outcomes of interest were QRS duration and LVEF at baseline and follow‐up in mid‐range heart failure. Data were extracted and summarized. A random‐effect model incorporating the potential heterogeneity was used to synthesize the results. Out of 1065 articles, 8 met the inclusion criteria for 211 mid‐range heart failure patients with an implant LBBAP across the 16 centers. The average implant success rate with lumenless pacing lead use was 91.3%, and 19 complications were reported among all 211 enrolled patients. During the average follow‐up of 9.1 months, the average LVEF was 39.8% at baseline and 50.5% at follow‐up (MD: 10.90%, 95% CI: 6.56−15.23, p < .01). Average QRS duration was 152.6 ms at baseline and 119.3 ms at follow‐up (MD: −34.51 ms, 95% CI: −60.00 to −9.02, p < .01). LBBAP could significantly reduce QRS duration and improve systolic function in a patient with LVEF between 35% and 50%. Application of LBBAP as a CRT strategy for HFmrEF may be a viable option.